SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
143 hedge funds and large institutions have $1.21B invested in SpringWorks Therapeutics in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 35 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
30% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $1.87M
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
57% less capital invested
Capital invested by funds: $2.79B → $1.21B (-$1.58B)
Holders
143
Holding in Top 10
4
Calls
$1.32M
Puts
$1.87M
Top Buyers
| 1 | +$56.5M | |
| 2 | +$48.2M | |
| 3 | +$33.6M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$13.4M |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$12.4M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$32M | |
| 3 | -$30M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18.4M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$16.6M |